These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12702237)

  • 1. Fear of bioterrorism and implications for public health preparedness.
    Dworkin MS; Ma X; Golash RG
    Emerg Infect Dis; 2003 Apr; 9(4):503-5. PubMed ID: 12702237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of a public health emergency.
    Ziskin LZ
    N J Med; 2005; 102(1-2):8. PubMed ID: 15790057
    [No Abstract]   [Full Text] [Related]  

  • 3. Coordinated response to reports of possible anthrax contamination, Idaho, 2001.
    Tengelsen L; Hudson R; Barnes S; Hahn C
    Emerg Infect Dis; 2002 Oct; 8(10):1093-5. PubMed ID: 12396922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory response to anthrax bioterrorism, New York City, 2001.
    Heller MB; Bunning ML; France ME; Niemeyer DM; Peruski L; Naimi T; Talboy PM; Murray PH; Pietz HW; Kornblum J; Oleszko W; Beatrice ST; ;
    Emerg Infect Dis; 2002 Oct; 8(10):1096-102. PubMed ID: 12396923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.
    Polyak CS; Macy JT; Irizarry-De La Cruz M; Lai JE; McAuliffe JF; Popovic T; Pillai SP; Mintz ED;
    Emerg Infect Dis; 2002 Oct; 8(10):1056-9. PubMed ID: 12396915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparedness for an anthrax attack.
    Franz DR
    Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heading-off anthrax at Hamilton, New Jersey: events of October 2001.
    Godyn JJ
    N J Med; 2005; 102(1-2):51-4. PubMed ID: 15790066
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid Nanopore Whole-Genome Sequencing for Anthrax Emergency Preparedness.
    McLaughlin HP; Bugrysheva JV; Conley AB; Gulvik CA; Cherney B; Kolton CB; Marston CK; Saile E; Swaney E; Lonsway D; Gargis AS; Kongphet-Tran T; Lascols C; Michel P; Villanueva J; Hoffmaster AR; Gee JE; Sue D
    Emerg Infect Dis; 2020 Feb; 26(2):358-361. PubMed ID: 31961318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax. Biodefense hampered by inadequate tests.
    Enserink M
    Science; 2001 Nov; 294(5545):1266-7. PubMed ID: 11701907
    [No Abstract]   [Full Text] [Related]  

  • 16. Update: Cutaneous anthrax in a laboratory worker--Texas, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(22):482. PubMed ID: 12064454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacillus anthracis and bioterrorism].
    Sabriá M
    Med Clin (Barc); 2001 Dec; 117(19):737-9. PubMed ID: 11738001
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioterrorism watch. They don't call it bioterror for nothing: fear is the foe when anthrax spores are found within hospital walls.
    Hosp Peer Rev; 2002 Jun; 27(6):suppl 1-3. PubMed ID: 12068508
    [No Abstract]   [Full Text] [Related]  

  • 19. Interim guidelines for investigation of and response to Bacillus anthracis exposures.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):987-90. PubMed ID: 11724154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gram-positive rod surveillance for early anthrax detection.
    Begier EM; Barrett NL; Mshar PA; Johnson DG; Hadler JL;
    Emerg Infect Dis; 2005 Sep; 11(9):1483-6. PubMed ID: 16229790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.